PAPER
Highly Functionalized Fused-Ring Heterocycles
3347
(Z)-2-(Benzothiazol-2-yl)-1-phenylvinyl Benzoate (17)
By following the typical procedure, starting from benzothiazole 8
(1.51 g, 10 mmol, 1 equiv), Et3N (3.71 g, 36.7 mmol, 3.7 equiv), and
BzCl (4.26 g, 30 mmol, 3 equiv), benzoate 17 was isolated as yellow
solid; yield: 1.89 g (53%); mp 146–148 °C; Rf = 0.54 (EtOAc–hex-
ane, 1:4).
Rf = 0.44 (EtOAc–hexane, 1:6). In CDCl3, the ratio of 20a to 20b
was 1:1.41.
IR (neat): 3089, 3055, 3038, 2980, 2918, 1630, 1573, 1555, 1492,
1454, 1268, 1146, 1060, 817, 770, 747, 687, 648 cm–1.
1H NMR (300 MHz, CDCl3): δ = 13.52 (br s, 1 H), 8.04 (d, J = 7.66
Hz, 2 H), 7.79 (d, J = 7.41 Hz, 2 H), 7.58 (t, J = 7.38 Hz, 1 H), 7.48
(t, J = 7.57 Hz, 2 H), 7.41–7.35 (m, 3 H), 6.19 (s, 1 H), 4.61 (s, 2 H),
2.32, 2.31, 2.30 (s, 12 H).
13C NMR (75 MHz, CDCl3): δ = 194.79, 164.01, 160.45, 157.33,
147.50, 145.00, 135.86, 135.10, 133.57, 129.32, 128.69, 128.52,
128.33, 127.27, 125.25, 121.56, 90.64, 42.92, 14.52, 14.24, 11.14.
IR (neat): 3061, 2981, 1739, 1641, 1596, 1452, 1445, 1432, 1227,
1209, 1175, 1080, 1055, 1023, 1000, 850, 754, 656 cm–1.
1H NMR (600 MHz, CDCl3): δ = 8.36 (d, J = 7.80 Hz, 2 H), 7.97 (d,
J = 8.19 Hz, 1 H), 7.73 (dd, J = 7.80, 7.61 Hz, 2 H), 7.65 (d,
J = 7.65 Hz, 2 H), 7.60 (dd, J = 7.65, 7.56 Hz, 2 H), 7.45–7.39 (m,
5 H), 7.31 (t, J = 7.56 Hz, 1 H).
13C NMR (150 MHz, CDCl3): δ = 163.71, 161.38, 152.57, 152.48,
135.05, 134.20, 133.73, 130.63, 130.05, 128.95, 128.88, 128.80,
126.25, 125.32, 125.21, 123.00, 121.29, 112.44.
(Z)-2-(4,5-Dimethyloxazol-2-yl)-1-phenylethenol (21a) and 2-
(4,5-Dimethyloxazol-2-yl)-1-phenylethanone (21b)
By following the typical procedure, starting from benzoate 6 (1.6 g,
5.1 mmol, 1 equiv) in anhyd MeOH (15 mL) and KOH (0.578 g,
10.3 mmol, 2 equiv) in MeOH (10 mL), tautomers 21a,b were iso-
lated as a dark-green oil; yield: 0.811 g (74%); Rf = 0.57 (EtOAc–
hexane, 1:6). In CDCl3, the ratio of 21a to 21b was 1:3.57.
(Z)-1-Phenyl-2-(thiazol-2-yl)ethenol (18a) and 1-Phenyl-2-(thia-
zol-2-yl)ethanone (18b): Typical Procedure
A soln of KOH (0.788 g, 14.04 mmol, 2 equiv) in MeOH (10 mL)
was added dropwise to a soln of benzoate 4 (2.144 g, 6.98 mmol, 1
equiv) in anhyd MeOH (15 mL), and the mixture was stirred for 24
h at r.t. MeOH was then removed by rotary evaporation and the res-
idue was dissolved in H2O (30 mL). The soln was neutralized with
1 M H2SO4 and extracted with CH2Cl2 (2 × 25 mL). The organic
layer was washed with H2O (30 mL), dried (Na2SO4), filtered, and
concentrated by rotary evaporation. The crude product was purified
by column chromatography [silica gel, EtOAc–hexane (1:4)] to
give a dark-green oil; yield: 1.273 g (90%); Rf = 0.48 (EtOAc–hex-
IR (neat): 3059, 2980, 2953, 2924, 2882, 1693, 1633, 1598, 1578,
1532, 1496, 1449, 1293, 1201, 1066, 1012, 756, 713, 688, 639, 618
cm–1.
1H NMR (600 MHz, CDCl3): δ = 7.94 (d, J = 7.66 Hz, 2 H), 7.71 (d,
J = 7.72 Hz, 2 H), 7.51 (m, 5 H), 7.32 (t, J = 7.56 Hz, 1 H), 5.91 (s,
1 H), 4.37 (s, 2 H), 2.17 (s, 3 H), 2.14 (s, 3 H), 2.03 (s, 3 H), 2.02 (s,
3 H); OH peak not seen.
13C NMR (75 MHz, CDCl3): δ = 193.28, 161.23, 160.92, 155.28,
143.98, 140.21, 135.63, 134.42, 133.49, 130.61, 129.41, 128.88,
128.57, 128.36, 128.22, 125.08, 84.01, 38.81, 10.88, 10.73, 9.75,
9.63.
1
ane, 1:3). H and 13C NMR in CDCl3 confirmed that the isolated
product consists of the tautomers 18a and 18b in a 1:2.0 ratio.
IR (neat): 3117, 3084, 3060, 1687, 1622, 1598, 1576, 1494, 1483,
1449, 1263, 1210, 1100, 1070, 752, 686, 632 cm–1.
(Z)-2-(Benzo[d]oxazol-2-yl)-1-phenylethenol (22a) and 2-(Ben-
zo[d]oxazol-2-yl)-1-phenylethanone (22b)
1H NMR (600 MHz, CDCl3): δ = 13.18 (br s, 1 H), 7.99 (d, J = 7.56
Hz, 2 H), 7.74 (d, J = 7.95 Hz, 2 H), 7.70 (d, J = 3.25 Hz, 1 H), 7.61
(d, J = 3.32 Hz, 1 H), 7.53 (t, J = 7.37 Hz, 2 H), 7.42 (t, J = 7.70 Hz,
2 H), 7.35–7.31 (m, 2 H), 7.26 (d, J = 3.25 Hz, 1 H), 7.00 (d,
J = 3.32 Hz, 1 H), 6.28 (s, 1 H), 4.69 (s, 2 H).
13C NMR (150 MHz, CDCl3): δ = 194.46, 168.35, 162.15, 160.64,
142.10, 140.11, 135.71, 134.60, 133.71, 129.63, 128.74, 128.52,
128.34, 125.42, 120.04, 114.39, 90.99, 42.65.
By following the typical procedure, starting from benzoate 16
(0.844 g, 2.47 mmol, 1 equiv) in anhyd MeOH (15 mL) and KOH
(0.28 g, 5.2 mmol, 2.1 equiv) in MeOH (10 mL), tautomers 22a,b
were isolated as a greenish-white solid; yield: 0.541 g (92%); mp
87–89 °C; Rf = 0.64 (EtOAc–hexane, 1:5). In CDCl3, the ratio of
22a to 22b was 1.06:1.
IR (neat): 3065, 3032, 3044, 2979, 1625, 1576, 1530, 1453, 1277,
1250, 1164, 1064, 850, 792, 743, 762, 702, 685 cm–1.
1H NMR (600 MHz, CDCl3): δ = 12.62 (br s, 1 H), 8.05 (d, J = 7.74
Hz, 2 H), 7.88 (m, 2 H), 7.72 (m, 1 H), 7.61 (m, 2 H), 7.52–7.45 (m,
7 H), 7.34–7.31 (m, 3 H), 7.28 (t, J = 7.66 Hz, 1 H), 6.21 (s, 1 H),
4.64 (s, 2 H).
13C NMR (150 MHz, CDCl3): δ = 192.38, 166.19, 165.68, 160.41,
151.24, 148.69, 141.26, 139.85, 135.66, 134.03, 133.91, 130.56,
128.85, 128.53, 128.53, 125.82, 124.98, 124.61, 124.32, 124.08,
119.95, 117.85, 110.61, 110.19, 83.66, 39.56.
(Z)-2-(4-Methylthiazol-2-yl)-1-phenylethenol (19a) and 2-(4-
Methylthiazol-2-yl)-1-phenylethanone (19b)
By following the typical procedure, starting from benzoate 15
(1.045 g, 3.25 mmol, 1 equiv) in anhyd MeOH (15 mL) and KOH
(0.365 g, 6.51 mmol) in MeOH (10 mL), tautomers 19a,b were iso-
lated as a yellow solid; yield: 0.473 g (66.9%); mp 96–97 °C;
Rf = 0.42 (EtOAc–hexane, 1:7). In CDCl3, the ratio of 19a to 19b
was 1:1.32.
IR (neat): 3106, 3053, 2956, 2918, 1608, 1574, 1519, 1492, 1454,
1259, 1035, 836, 758 cm–1.
(Z)-2-(Benzo[d]thiazol-2-yl)-1-phenylethenol (23a) and 2-(Ben-
zo[d]thiazol-2-yl)-1-phenylethanone (23b)
1H NMR (300 MHz, CDCl3): δ = 13.44 (br s, 1 H), 7.98 (d, J = 7.23
Hz, 2 H), 7.74–7.72 (d, J = 7.73 Hz, 2 H), 7.52 (t, J = 6.90 Hz, 1 H),
7.42 (t, J = 7.79 Hz, 2 H), 7.37–7.42 (m, 3 H), 6.79 (d, J = 0.71 Hz,
1 H), 6.53 (d, J = 0.74 Hz, 1 H), 6.21 (s, 1 H), 4.63 (s, 2 H), 2.37 (s,
J = 0.75 Hz, 3 H), 2.35 (d, J = 0.78 Hz, 3 H).
13C NMR (75 MHz, CDCl3): δ = 194.58, 167.58, 161.37, 160.52,
152.02, 150.11, 135.61, 134.67, 133.70, 129.53 128.27, 128.44,
128.37, 125.30, 114.56, 108.92, 91.06, 42.68, 16.95, 16.68.
By following the typical procedure, starting from benzoate 17
(1.008 g, 2.82 mmol, 1 equiv) in anhyd MeOH (15 mL) and KOH
(0.316 g, 5.63 mmol, 2 equiv) in MeOH (10 mL), tautomers 23a,b
were isolated as a yellowish-green solid; yield: 0.516 g (73%); mp
111–112 °C; Rf = 0.64 (EtOAc–hexane, 1:5). In CDCl3, the ratio of
23a to 23b was 1.63:1.
IR (neat): 3057, 2922, 1610, 1596, 1573, 1494, 1473, 1436, 1378,
1264, 1249, 1136, 1057, 751, 729, 687, 668 cm–1.
(Z)-2-(4,5-Dimethylthiazol-2-yl)-1-phenylethenol (20a) and 2-
(4,5-Dimethylthiazol-2-yl)-1-phenylethanone (20b)
By following the typical procedure, starting from benzoate 5 (0.502
g, 1.50 mmol, 1 equiv) in anhyd MeOH (10 mL) and KOH (0.168
g, 2.99 mmol, 2 equiv) in MeOH (10 mL), tautomers 20a,b were
isolated as a yellow solid; yield: 0.308 g (85%); mp 80–81 °C;
1H NMR (600 MHz, CDCl3): δ = 13.91 (br s, 1 H), 8.07 (d, J = 7.68
Hz, 2 H), 7.99 (d, J = 8.13 Hz, 1 H), 7.85–7.87 (m, 3 H), 7.80 (d,
J = 8.10 Hz, 1 H), 7.76 (d, J = 7.93 Hz, 1 H), 7.58 (dd, J = 8.13,
7.91 Hz, 1 H), 7.48 (dd, J = 7.68, 7.53 Hz, 2 H), 7.41–7.46 (m, 5 H),
7.36 (t, J = 7.53 Hz, 1 H), 7.27 (t, J = 7.53 Hz, 1 H), 6.35 (s, 1 H),
4.81 (s, 2 H).
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2012, 44, 3337–3352